ANALYSIS: What Would A Teva-Mylan Deal Mean For India?
This article was originally published in PharmAsia News
Executive Summary
The situation is still fluid on a possible merger between Teva and Mylan and will likely see a few quick and dramatic turns over the next few weeks. In the event a deal does click, it would have a significant impact on the two firms’ Indian businesses and also Indian generic manufacturers more generally.